Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors

Molecular Endocrinology

Volumn 21, Issue 11, 2007, Pages 2672-2686

  Das, Sharmistha ^a   Schapira, Matthieu ^b   Tomic Canic, Marjana ^c   Goyanka, Ritu ^a   Cardozo, Timothy ^a   Samuels, Herbert H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CHOLESTEROL; FARNESOID X RECEPTOR; FARNESYL DIPHOSPHATE; LIGAND; LIVER X RECEPTOR; NUCLEAR RECEPTOR NUR77; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN FARNESYLTRANSFERASE INHIBITOR; SQUALENE SYNTHASE; THYROID HORMONE RECEPTOR BETA;

AGONIST; ARTICLE; CHEMICAL STRUCTURE; CHOLESTEROL SYNTHESIS; COMPUTER MODEL; LIGAND BINDING; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; TRANSCRIPTION INITIATION;

CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYISOPRENYL PHOSPHATES; PRENYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, THYROID HORMONE; SESQUITERPENES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 35649022675     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0080     Document Type: Article

References (70)

1. Aranda A, Pascual A 2001 Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304
2. Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, Kliewer SA 2006 International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor α, farnesoid X receptor β, liver X receptor α, liver X receptor β, and vitamin D receptor. Pharmacol Rev 58:742-759
3. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H 2006 International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev 58:760-772
4. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H 2006 International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 58:712-725
5. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W 2006 International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58:726-741
6. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V 2006 International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 58:798-836
7. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA 2006 International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58:773-781
8. Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA 2006 International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 58:782-797
9. Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, Scanlan TS, Vennstrom B, Samarut J 2006 International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev 58:705-711
10. Gronemeyer H, Gustafsson JA, Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3:950-964
11. Ingraham HA, Redinbo MR 2005 Orphan nuclear receptors adopted by crystallography. Curr Opin Struct Biol 15:708-715
12. Bourguet W, Germain P, Gronemeyer H 2000 Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21:381-388
13. Smith CL, O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71
14. Mahajan MA, Samuels HH 2005 Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development. Endocr Rev 26:583-597
15. Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE 2002 Crystal structure of the HNF4 α ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 277:37973-37976
16. Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D, Schule R 2003 Alltrans retinoic acid is a ligand for the orphan nuclear receptor ROR β. Nat Struct Biol 10:820-825
17. Wisely GB, Miller AB, Davis RG, Thornquest Jr AD, Johnson R, Spitzer T, Sefler A, Shearer B, Moore JT, Miller AB, Willson TM, Williams SP 2002 Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10:1225-1234
18. Harris JM, Lau P, Chen SL, Muscat GE 2002 Characterization of the retinoid orphan-related receptor-α coactivator binding interface: a structural basis for ligand-independent transcription. Mol Endocrinol 16:998-1012
19. Stehlin C, Wurtz JM, Steinmetz A, Greiner E, Schule R, Moras D, Renaud JP 2001 X-ray structure of the orphan nuclear receptor RORβ ligand-binding domain in the active conformation. EMBO J 20:5822-5831
20. Billas IM, Moulinier L, Rochel N, Moras D 2001 Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J Biol Chem 276:7465-7474
21. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D 2000 Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell 5:289-298
22. Clayton GM, Peak-Chew SY, Evans RM, Schwabe JW 2001 The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc Natl Acad Sci USA 98:1549-1554
23. Benoit G, Malewicz M, Perlmann T 2004 Digging deep into the pockets of orphan nuclear receptors: insights from structural studies. Trends Cell Biol 14:369-376
24. Ortlund EA, Lee Y, Solomon IH, Hager JM, Safi R, Choi Y, Guan Z, Tripathy A, Raetz CR, McDonnell DP, Moore DD, Redinbo MR 2005 Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat Struct Mol Biol 12:357-363
25. Wang W, Zhang C, Marimuthu A, Krupka HI, Tabrizizad M, Shelloe R, Mehra U, Eng K, Nguyen H, Settachatgul C, Powell B, Milburn MV, West BL 2005 The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci USA 102:7505-7510
26. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V, Lebedeva L, Suzawa M, Williams JD, Williams SP, Guy RK, Thornton JW, Fletterick RJ, Willson TM, Ingraham HA 2005 Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343-355
27. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, Xu HE 2005 Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17:491-502
28. Escriva H, Bertrand S, Laudet V 2004 The evolution of the nuclear receptor superfamily. Essays Biochem 40:11-26
29. Escriva H, Safi R, Hanni C, Langlois MC, Saumitou-Laprade P, Stehelin D, Capron A, Pierce R, Laudet V 1997 Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 94: 6803-6808
30. Schapira M, Raaka BM, Das S, Fan L, Totrov M, Zhou Z, Wilson SR, Abagyan R, Samuels HH 2003 Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc Natl Acad Sci USA 100:7354-7359
31. Schapira M, Raaka BM, Samuels HH, Abagyan R 2001 In silico discovery of novel retinoic acid receptor agonist structures. BMC Struct Biol 1:1
32. Schapira M, Raaka BM, Samuels HH, Abagyan R 2000 Rational discovery of novel nuclear hormone receptor antagonists. Proc Natl Acad Sci USA 97:1008-1013
33. Abagyan R, Totrov M 2001 High-throughput docking for lead generation. Curr Opin Chem Biol 5:375-382
34. Selmi-Ruby S, Casanova J, Malhotra S, Roussett B, Raaka BM, Samuels HH 1998 Role of the conserved C-terminal region of thyroid hormone receptor-α in ligand-dependent transcriptional activation. Mol Cell Endocrinol 138:105-114
35. Keller RK 1996 Squalene synthase inhibition alters metabolism of nonsterols in rat liver. Biochim Biophys Acta 1303:169-179
36. Tong H, Holstein SA, Hohl RJ 2005 Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. Anal Biochem 336:51-59
37. Belles X, Martin D, Piulachs MD 2005 The mevalonate pathway and the synthesis of juvenile hormone in insects. Annu Rev Entomol 50:181-199
38. Jones G, Jones D, Teal P, Sapa A, Wozniak M 2006 The retinoid-X receptor ortholog, ultraspiracle, binds with nanomolar affinity to an endogenous morphogenetic ligand. FEBS J 273:4983-4996
39. Xu Y, Fang F, Chu Y, Jones D, Jones G 2002 Activation of transcription through the ligand-binding pocket of the orphan nuclear receptor ultraspiracle. Eur J Biochem 269:6026-6036
40. Keay J, Bridgham JT, Thornton JW 2006 The Octopus vulgaris estrogen receptor is a constitutive transcriptional activator: evolutionary and functional implications. Endocrinology 147:3861-3869
41. Mahajan MA, Samuels HH 2000 A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol Cell Biol 20:5048-5063
42. Stancato LF, Hutchison KA, Krishna P, Pratt WB 1996 Animal and plant cell lysates share a conserved chaperone system that assembles the glucocorticoid receptor into a functional heterocomplex with hsp90. Biochemistry 35:554-561
43. Cardozo T, Totrov M, Abagyan R 1995 Homology modeling by the ICM method. Proteins 23:403-414
44. Cavasotto CN, Orry AJ, Abagyan RA 2003 Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors. Proteins 51:423-433
45. Cavasotto CN, Ortiz MA, Abagyan RA, Piedrafita FJ 2006 In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells. Bioorg Med Chem Lett 16:1969-1974
46. Schapira M, Abagyan R, Totrov M 2003 Nuclear hormone receptor targeted virtual screening. J Med Chem 46:3045-3059
47. Prendergast GC, Oliff A 2000 Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects. Semin Cancer Biol 10:443-452
48. Doisneau-Sixou SF, Cestac P, Chouini S, Carroll JS, Hamilton AD, Sebti SM, Poirot M, Balaguer P, Faye JC, Sutherland RL, Favre G 2003 Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells. Endocrinology 144:989-998
49. Bonetti PO, Lerman LO, Napoli C, Lerman A 2003 Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 24:225-248
50. Chan KK, Oza AM, Siu LL 2003 The statins as anticancer agents. Clin Cancer Res 9:10-19
51. Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G 2000 Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231-241
52. Tozawa R, Ishibashi S, Osuga J, Yagyu H, Oka T, Chen Z, Ohashi K, Perrey S, Shionoiri F, Yahagi N, Harada K, Gotoda T, Yazaki Y, Yamada N 1999 Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem 274:30843-30848
53. Steele CE, Trasler DG, New DA 1983 An in vivo/in vitro evaluation of the teratogenic action of excess vitamin A. Teratology 28:209-214
54. Amano Y, Nishimoto T, Tozawa R, Ishikawa E, Imura Y, Sugiyama Y 2003 Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia. Eur J Pharmacol 466:155-161
55. Davidson MH 2007 Squalene synthase inhibition: a novel target for the management of dyslipidemia. Curr Atheroscler Rep 9:78-80
56. Mahajan MA, Murray A, Samuels HH 2002 NRC-interacting factor 1 is a novel cotransducer that interacts with and regulates the activity of the nuclear hormone receptor coactivator NRC. Mol Cell Biol 22:6883-6894
57. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM 1995 15-Deoxy-δ 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ. Cell 83:803-812
58. Wang H, Chen J, Hollister K, Sowers LC, Forman BM 1999 Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543-553
59. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, Mangelsdorf DJ 1999 Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc Natl Acad Sci USA 96:266-271
60. Suzuki T, Kasahara M, Yoshioka H, Morohashi K, Umesono K 2003 LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol Cell Biol 23:238-249
61. Heard DJ, Norby PL, Holloway J, Vissing H 2000 Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol Endocrinol 14:382-392
62. Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD 2000 The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol 20:187-195
63. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ 2000 Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515
64. Willy PJ, Murray IR, Qian J, Busch BB, Stevens Jr WC, Martin R, Mohan R, Zhou S, Ordentlich P, Wei P, Sapp DW, Horlick RA, Heyman RA, Schulman IG 2004 Regulation of PPARγ coactivator 1α(PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand. Proc Natl Acad Sci USA 101:8912-8917
65. Baker KD, Warren JT, Thummel CS, Gilbert LI, Mangelsdorf DJ 2000 Transcriptional activation of the Drosophila ecdysone receptor by insect and plant ecdysteroids. Insect Biochem Mol Biol 30:1037-1043
66. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA 2007 The human glucocorticoid receptor-β (hGRβ) binds RU-486 and is transcriptionally active. Mol Cell Biol 27:2266-2282
67. Thornton JW, Need E, Crews D 2003 Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 301:1714-1717
68. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP 2003 Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15
69. Tusher VG, Tibshirani R, Chu G 2001 Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
70. Abagyan R, Totrov M 1994 Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol 235:983-1002